Sharechat Logo

AFT Pharmaceuticals Limited (NZX: AFT) 24-hour Efficacy for Crystawash Extend Hand Sanitiser

Monday 11th January 2021

Text too small?

AFT Pharmaceuticals today announces independent laboratories have found that its new Crystawash Extend Hand Sanitiser:

• Displays 24-hour residual efficacy against germs evidenced by testing on synthetic skin against S.Aureus and E.Coli

• Kills 99.99% of germs on immediate contact being S.Aureus, E.Coli, P.aeruginosa, and E. hirae

• Meets the accepted standard for killing Corona virus, evidenced by activity against the Corona virus surrogate [Murine hepatitis virus (MHV1)

The newly developed, ethanol free, foaming formulation adds to AFT’s existing Crystawash sanitiser range in Australia and New Zealand and meets the huge demand for hand sanitiser that has emerged with the Covid-19 pandemic. It also enhances the appeal of AFT’s over-the-counter portfolio of medicines, now sold in more than 6,000 pharmacies and other outlets across Australasia.

Dr Atkinson said Crystawash Extend sales will add to this financial year’s results in Australia and New Zealand and also has potential around the world as AFT leverages its global network of partners to out-license the product in other jurisdictions. Already Canada’s CombomedPharma Inc has agreed to distribute Crystawash Extend in that country and more agreements are expected to follow.

See the links below for more details:

24-hour efficacy for Crystawash Extend Hand Sanitiser

Source: AFT Pharmaceuticals Limited



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Ebos Group Limited (NZX: EBO) Retail Offer Oversubscribed
24th January 2022 Morning Report
ArborGen Holdings Limited (NZX: ARB) Updates Market on FY22 Guidance
My Food Bag Group Limited (NZX: MFB) Q3 FY22 Trading Update
ikeGPS Group Limited (NZX: IKE) signs $0.9m deal with tier-1 electric utility
Tower Limited (NZX: TWR) Update on Tonga Volcanic Eruption and Tsunami Event
21st January 2022 Morning Report
Trade Window Holdings Limited (NZX: TWL) TradeWindow and Mastercard teams up
Genesis Energy Limited (NZX: GNE) FY22 Q2 Performance Report
Seeka Limited (NZX: SEK) Seeka announces dividend of 13 cents per share